يعرض 1 - 9 نتائج من 9 نتيجة بحث عن '"IPILIMUMAB"', وقت الاستعلام: 1.38s تنقيح النتائج
  1. 1
    مورد إلكتروني

    مصطلحات الفهرس: Cushing syndrome, disease association, dyspnea, epigastric pain, fatigue/dt [Drug Therapy], fatigue/si [Side Effect], febrile neutropenia/si [Side Effect], flank pain, heart right atrium, hepatitis/dt [Drug Therapy], hereditary nonpolyposis colorectal cancer/dt [Drug Therapy], adrenal cortex carcinoma/dt [Drug Therapy], adrenal cortex carcinoma/su [Surgery], adrenal insufficiency/dt [Drug Therapy], adrenalectomy, adult, alanine aminotransferase blood level, aspartate aminotransferase blood level, cancer combination chemotherapy, cancer immunotherapy, cancer regression, case report, clinical article, computer assisted tomography, histology, human, hydrocortisone blood level, hydrocortisone urine level, hyperkalemia, hyperthyroidism, hypogonadism, hyponatremia, hypotension/si [Side Effect], inferior cava vein, kidney vein, letter, libido disorder/dt [Drug Therapy], liver metastasis/di [Diagnosis], liver metastasis/dt [Drug Therapy], lung embolism/di [Diagnosis], lung metastasis/di [Diagnosis], lung metastasis/dt [Drug Therapy], male, nausea/si [Side Effect], nephrectomy, orchitis, pain/dt [Drug Therapy], pain/si [Side Effect], peripheral neuropathy/si [Side Effect], priority journal, thorax pain, thrombectomy, thrombus/di [Diagnosis], thyroiditis, unspecified side effect/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], aspartate aminotransferase/ec [Endogenous Compound], cisplatin/ae [Adverse Drug Reaction], cisplatin/dt [Drug Therapy], corticotropin/ec [Endogenous Compound], dexamethasone, etoposide/ae [Adverse Drug Reaction], etoposide/dt [Drug Therapy], fludrocortisone/dt [Drug Therapy], follitropin/ec [Endogenous Compound], hydrocortisone/dt [Drug Therapy], hydrocortisone/ec [Endogenous Compound], ipilimumab/ae [Adverse Drug Reaction], ipilimumab/cb [Drug Combination], ipilimumab/dt [Drug Therapy], liotrix, luteinizing hormone/ec [Endogenous Compound], mitotane, nivolumab/ae [Adverse Drug Reaction], nivolumab/cb [Drug Combination], nivolumab/dt [Drug Therapy], oxycodone/dt [Drug Therapy], prednisolone/dt [Drug Therapy], Letter

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29194Test
    Clinical Endocrinology
    Click here for full text options
    LibKey Link

  2. 2
    مورد إلكتروني

    مصطلحات الفهرس: cross infection, digital rectal examination, epidemiological data, hormone action, immunocompromised patient, infection prevention, intensity modulated radiation therapy, mixed infection, nonhuman, papillomavirus infection, pathophysiology, positron emission tomography-computed tomography, prevalence, radiation injury, review, risk assessment, risk factor, salvage therapy, sexual behavior, sexually transmitted disease, smoking habit, treatment duration, treatment response, trend study, uterine cervix cancer, viral clearance, virus strain, atezolizumab/cb [Drug Combination], atezolizumab/dt [Drug Therapy], avelumab/cb [Drug Combination], avelumab/cm [Drug Comparison], capecitabine/ct [Clinical Trial], capecitabine/dt [Drug Therapy], carboplatin/ct [Clinical Trial], carboplatin/cb [Drug Combination], carboplatin/dt [Drug Therapy], cetuximab/ct [Clinical Trial], cetuximab/cb [Drug Combination], cetuximab/cm [Drug Comparison], cetuximab/dt [Drug Therapy], circulating tumor DNA/ec [Endogenous Compound], cisplatin/ct [Clinical Trial], cisplatin/cb [Drug Combination], cisplatin/cm [Drug Comparison], cisplatin/dt [Drug Therapy], docetaxel/cb [Drug Combination], docetaxel/cm [Drug Comparison], docetaxel/dt [Drug Therapy], durvalumab/dt [Drug Therapy], estrogen, fluorouracil/ae [Adverse Drug Reaction], fluorouracil/ct [Clinical Trial], fluorouracil/cb [Drug Combination], fluorouracil/cm [Drug Comparison], fluorouracil/dt [Drug Therapy], ipilimumab/cb [Drug Combination], ipilimumab/cm [Drug Comparison], ipilimumab/dt [Drug Therapy], mitomycin/ae [Adverse Drug Reaction], mitomycin/cb [Drug Combination], mitomycin/dt [Drug Therapy], nivolumab/ct [Clinical Trial], nivolumab/cb [Drug Combination], nivolumab/cm [Drug Comparison], nivolumab/dt [Drug Therapy], pembrolizumab/ct [Clinical Trial], pembrolizumab/dt [Drug Therapy], Wart virus vaccine, human, adoptive transfer, anus cancer/di [Diagnosis], anus cancer/dt [Drug Therapy], anus cancer/ep [Epidemiology], anus cancer/rt [Radiotherapy], anus cancer/th [Therapy], blood toxicity/si [Side Effect], cancer growth, cancer immunotherapy, cancer incidence, cancer mortality, cancer prognosis, cancer radiotherapy, cancer screening, cancer staging, chemoradiotherapy, colposcopy, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29105Test
    Expert Review of Gastroenterology and Hepatology
    LibKey Link

  3. 3
    مورد إلكتروني

    مصطلحات الفهرس: Cushing syndrome, disease association, dyspnea, epigastric pain, fatigue/dt [Drug Therapy], fatigue/si [Side Effect], febrile neutropenia/si [Side Effect], flank pain, heart right atrium, hepatitis/dt [Drug Therapy], hereditary nonpolyposis colorectal cancer/dt [Drug Therapy], adrenal cortex carcinoma/dt [Drug Therapy], adrenal cortex carcinoma/su [Surgery], adrenal insufficiency/dt [Drug Therapy], adrenalectomy, adult, alanine aminotransferase blood level, aspartate aminotransferase blood level, cancer combination chemotherapy, cancer immunotherapy, cancer regression, case report, clinical article, computer assisted tomography, histology, human, hydrocortisone blood level, hydrocortisone urine level, hyperkalemia, hyperthyroidism, hypogonadism, hyponatremia, hypotension/si [Side Effect], inferior cava vein, kidney vein, letter, libido disorder/dt [Drug Therapy], liver metastasis/di [Diagnosis], liver metastasis/dt [Drug Therapy], lung embolism/di [Diagnosis], lung metastasis/di [Diagnosis], lung metastasis/dt [Drug Therapy], male, nausea/si [Side Effect], nephrectomy, orchitis, pain/dt [Drug Therapy], pain/si [Side Effect], peripheral neuropathy/si [Side Effect], priority journal, thorax pain, thrombectomy, thrombus/di [Diagnosis], thyroiditis, unspecified side effect/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], aspartate aminotransferase/ec [Endogenous Compound], cisplatin/ae [Adverse Drug Reaction], cisplatin/dt [Drug Therapy], corticotropin/ec [Endogenous Compound], dexamethasone, etoposide/ae [Adverse Drug Reaction], etoposide/dt [Drug Therapy], fludrocortisone/dt [Drug Therapy], follitropin/ec [Endogenous Compound], hydrocortisone/dt [Drug Therapy], hydrocortisone/ec [Endogenous Compound], ipilimumab/ae [Adverse Drug Reaction], ipilimumab/cb [Drug Combination], ipilimumab/dt [Drug Therapy], liotrix, luteinizing hormone/ec [Endogenous Compound], mitotane, nivolumab/ae [Adverse Drug Reaction], nivolumab/cb [Drug Combination], nivolumab/dt [Drug Therapy], oxycodone/dt [Drug Therapy], prednisolone/dt [Drug Therapy], Letter

  4. 4
    مورد إلكتروني

    مصطلحات الفهرس: lung disease/si [Side Effect], lung infection/si [Side Effect], maculopapular rash/si [Side Effect], major clinical study, median survival time, mouth inflammation/si [Side Effect], multicenter study, multiple cycle treatment, multiple organ failure/si [Side Effect], nausea/si [Side Effect], neutrophil count, open study, overall survival, pancreatitis/si [Side Effect], patient risk, phase 3 clinical trial, platelet count, pneumonia/si [Side Effect], priority journal, progression free survival, randomized controlled trial, rash/si [Side Effect], renal cell carcinoma/dt [Drug Therapy], side effect/si [Side Effect], skin disease/si [Side Effect], skin exfoliation/si [Side Effect], skin pruritus/si [Side Effect], stomatitis/si [Side Effect], thrombocytopenia/si [Side Effect], thyroiditis/si [Side Effect], urticaria/si [Side Effect], vomiting/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], aminotransferase/ec [Endogenous Compound], aspartate aminotransferase/ec [Endogenous Compound], bilirubin/ec [Endogenous Compound], creatinine/ec [Endogenous Compound], gamma glutamyltransferase/ec [Endogenous Compound], ipilimumab/ae [Adverse Drug Reaction], ipilimumab/ct [Clinical Trial], ipilimumab/cb [Drug Combination], ipilimumab/cm [Drug Comparison], ipilimumab/dt [Drug Therapy], ipilimumab/iv [Intravenous Drug Administration], nivolumab/ae [Adverse Drug Reaction], nivolumab/ct [Clinical Trial], nivolumab/cb [Drug Combination], nivolumab/cm [Drug Comparison], nivolumab/dt [Drug Therapy], nivolumab/iv [Intravenous Drug Administration], sunitinib/ae [Adverse Drug Reaction], sunitinib/ct [Clinical Trial], sunitinib/cm [Drug Comparison], sunitinib/dt [Drug Therapy], sunitinib/po [Oral Drug Administration], colitis/si [Side Effect], acute kidney failure/si [Side Effect], adrenal insufficiency/si [Side Effect], adult, advanced cancer/dt [Drug Therapy], alanine aminotransferase blood level, anemia/si [Side Effect], aplastic anemia/si [Side Effect], article, aspartate aminotransferase blood level, asthenia/si [Side Effect], bilirubin blood level, blister/si [Side Effect], bronchitis/si [Side Effect], controlled study, creatinine blood level, creatinine clearance, diabetes mellitus/si [Side Effect], diarrhea/si [Side Effect], drug efficacy, drug response, drug safety, drug withdrawal, dysgeusia/si [Side Effect], dyspepsia/si [Side Effect], eczema/si [Side Effect], endocrine disease/si [Side Effect], erythema/si [Side Effect], fatigue/si [Side Effect], gastrointestinal disease/si [Side Effect], gastrointestinal hemorrhage/si [Side Effect], hand foot syndrome/si [Side Effect], heart arrest/si [Side Effect], heart failure/si [Side Effect], hemophagocytic syndrome/si [Side Effect], human, hypertension/si [Side Effect], hyperthyroidism/si [Side Effect], hypertransaminasemia/si [Side Effect], hypophysitis/si [Side Effect], hypopigmentation/si [Side Effect], hypothyroidism/si [Side Effect], interactive voice response system, intermediate risk patient, kidney disease/si [Side Effect], leukocyte count, liver disease/si [Side Effect], liver metastasis/co [Complication], liver metastasis/di [Diagnosis], liver toxicity/si [Side Effect], loss of appetite/si [Side Effect], Article

    URL: The Lancet Oncology
    Click here for full text options
    LibKey Link

  5. 5
    مورد إلكتروني

    مصطلحات الفهرس: lung disease/si [Side Effect], lung infection/si [Side Effect], maculopapular rash/si [Side Effect], major clinical study, median survival time, mouth inflammation/si [Side Effect], multicenter study, multiple cycle treatment, multiple organ failure/si [Side Effect], nausea/si [Side Effect], neutrophil count, open study, overall survival, pancreatitis/si [Side Effect], patient risk, phase 3 clinical trial, platelet count, pneumonia/si [Side Effect], priority journal, progression free survival, randomized controlled trial, rash/si [Side Effect], renal cell carcinoma/dt [Drug Therapy], side effect/si [Side Effect], skin disease/si [Side Effect], skin exfoliation/si [Side Effect], skin pruritus/si [Side Effect], stomatitis/si [Side Effect], thrombocytopenia/si [Side Effect], thyroiditis/si [Side Effect], urticaria/si [Side Effect], vomiting/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], aminotransferase/ec [Endogenous Compound], aspartate aminotransferase/ec [Endogenous Compound], bilirubin/ec [Endogenous Compound], creatinine/ec [Endogenous Compound], gamma glutamyltransferase/ec [Endogenous Compound], ipilimumab/ae [Adverse Drug Reaction], ipilimumab/ct [Clinical Trial], ipilimumab/cb [Drug Combination], ipilimumab/cm [Drug Comparison], ipilimumab/dt [Drug Therapy], ipilimumab/iv [Intravenous Drug Administration], nivolumab/ae [Adverse Drug Reaction], nivolumab/ct [Clinical Trial], nivolumab/cb [Drug Combination], nivolumab/cm [Drug Comparison], nivolumab/dt [Drug Therapy], nivolumab/iv [Intravenous Drug Administration], sunitinib/ae [Adverse Drug Reaction], sunitinib/ct [Clinical Trial], sunitinib/cm [Drug Comparison], sunitinib/dt [Drug Therapy], sunitinib/po [Oral Drug Administration], colitis/si [Side Effect], acute kidney failure/si [Side Effect], adrenal insufficiency/si [Side Effect], adult, advanced cancer/dt [Drug Therapy], alanine aminotransferase blood level, anemia/si [Side Effect], aplastic anemia/si [Side Effect], article, aspartate aminotransferase blood level, asthenia/si [Side Effect], bilirubin blood level, blister/si [Side Effect], bronchitis/si [Side Effect], controlled study, creatinine blood level, creatinine clearance, diabetes mellitus/si [Side Effect], diarrhea/si [Side Effect], drug efficacy, drug response, drug safety, drug withdrawal, dysgeusia/si [Side Effect], dyspepsia/si [Side Effect], eczema/si [Side Effect], endocrine disease/si [Side Effect], erythema/si [Side Effect], fatigue/si [Side Effect], gastrointestinal disease/si [Side Effect], gastrointestinal hemorrhage/si [Side Effect], hand foot syndrome/si [Side Effect], heart arrest/si [Side Effect], heart failure/si [Side Effect], hemophagocytic syndrome/si [Side Effect], human, hypertension/si [Side Effect], hyperthyroidism/si [Side Effect], hypertransaminasemia/si [Side Effect], hypophysitis/si [Side Effect], hypopigmentation/si [Side Effect], hypothyroidism/si [Side Effect], interactive voice response system, intermediate risk patient, kidney disease/si [Side Effect], leukocyte count, liver disease/si [Side Effect], liver metastasis/co [Complication], liver metastasis/di [Diagnosis], liver toxicity/si [Side Effect], loss of appetite/si [Side Effect], Article

  6. 6
    مورد إلكتروني

    مصطلحات الفهرس: insulin dependent diabetes mellitus/si [Side Effect], insulin dependent diabetes mellitus/dt [Drug Therapy], insulin resistance, intestine obstruction, intussusception, male, metastatic melanoma/di [Diagnosis], metastatic melanoma/dt [Drug Therapy], metastatic melanoma/rt [Radiotherapy], metastatic melanoma/su [Surgery], middle aged, multiple cycle treatment, nuclear magnetic resonance imaging, polydipsia/si [Side Effect], polyuria/si [Side Effect], positron emission tomography, priority journal, thorax radiography, thyroid disease, C peptide/ec [Endogenous Compound], glucocorticoid/dt [Drug Therapy], glucose/ec [Endogenous Compound], hemoglobin A1c/ec [Endogenous Compound], insulin/dt [Drug Therapy], insulin/sc [Subcutaneous Drug Administration], ipilimumab/dt [Drug Therapy], ipilimumab/iv [Intravenous Drug Administration], liothyronine/ec [Endogenous Compound], pembrolizumab/ae [Adverse Drug Reaction], pembrolizumab/dt [Drug Therapy], pembrolizumab/iv [Intravenous Drug Administration], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], protein S 100/ec [Endogenous Compound], thyrotropin/ec [Endogenous Compound], thyroxine/ec [Endogenous Compound], transcription factor Sox10/ec [Endogenous Compound], multimodality cancer therapy, adult, article, case report, computer assisted tomography, coughing, diabetic ketoacidosis/dt [Drug Therapy], diabetic ketoacidosis/si [Side Effect], differential diagnosis, drug dose escalation, drug withdrawal, dyspnea, hemicolectomy, histopathology, human, hyperglycemia, insulin deficiency, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40485Test
    BMJ Case Reports
    Click here for full text options
    LibKey Link

  7. 7
    مورد إلكتروني

    مصطلحات الفهرس: insulin dependent diabetes mellitus/si [Side Effect], insulin dependent diabetes mellitus/dt [Drug Therapy], insulin resistance, intestine obstruction, intussusception, male, metastatic melanoma/di [Diagnosis], metastatic melanoma/dt [Drug Therapy], metastatic melanoma/rt [Radiotherapy], metastatic melanoma/su [Surgery], middle aged, multiple cycle treatment, nuclear magnetic resonance imaging, polydipsia/si [Side Effect], polyuria/si [Side Effect], positron emission tomography, priority journal, thorax radiography, thyroid disease, C peptide/ec [Endogenous Compound], glucocorticoid/dt [Drug Therapy], glucose/ec [Endogenous Compound], hemoglobin A1c/ec [Endogenous Compound], insulin/dt [Drug Therapy], insulin/sc [Subcutaneous Drug Administration], ipilimumab/dt [Drug Therapy], ipilimumab/iv [Intravenous Drug Administration], liothyronine/ec [Endogenous Compound], pembrolizumab/ae [Adverse Drug Reaction], pembrolizumab/dt [Drug Therapy], pembrolizumab/iv [Intravenous Drug Administration], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], protein S 100/ec [Endogenous Compound], thyrotropin/ec [Endogenous Compound], thyroxine/ec [Endogenous Compound], transcription factor Sox10/ec [Endogenous Compound], multimodality cancer therapy, adult, article, case report, computer assisted tomography, coughing, diabetic ketoacidosis/dt [Drug Therapy], diabetic ketoacidosis/si [Side Effect], differential diagnosis, drug dose escalation, drug withdrawal, dyspnea, hemicolectomy, histopathology, human, hyperglycemia, insulin deficiency, Article

  8. 8
    مورد إلكتروني
  9. 9
    مورد إلكتروني